Revolutionary Breakthrough: IISc Researchers Unveil Game-Changing Imaging Method for Early Tumor Detection
Researchers at the Indian Institute of Science (IISc) in Bengaluru have made significant strides in cancer detection with the development of a groundbreaking imaging molecule called GPc. This innovative compound could revolutionize how tumors are diagnosed, offering a safer, more cost-effective alternative to current imaging techniques, particularly for tumors located near the surface of the body.
Tumor cells are considerably more active than healthy cells, often consuming much more glucose. Current gold-standard imaging methods, such as Positron Emission Tomography (PET) scans, exploit this difference by using a radioactive sugar molecule known as 18F-FDG. When injected into patients, this sugar accumulates in tumors, allowing for their identification. However, PET scans come with hefty price tags and expose patients to potentially harmful radiation, especially with repeated use.
In contrast, Photoacoustic (PA) Tomography offers a safer imaging approach. This technique employs a near-infrared laser directed at specialized light-absorbing molecules, or chromophores. When these chromophores absorb light, they undergo slight expansions, emitting tiny pressure waves that can be captured as sound signals and transformed into 3D images. Not only is PA Tomography less expensive than PET or MRI scans, but it is also particularly effective for locating superficial tumors.
Currently, clinical PA imaging often relies on natural chromophores present in the body, such as hemoglobin. While these signals can provide useful information, they are often too weak for specific diagnostic requirements. This is where IISc’s GPc molecule comes into play. Researchers conducted extensive experiments to determine whether GPc could enter cells similarly to glucose and if it would compete with glucose for cellular entry. Given its potential to function as a glucose “agonist,” it was crucial to ascertain GPc’s ability to act as a reliable imaging agent.
The findings were encouraging. GPc was found to easily infiltrate tumor cells, remain unprocessed, and operate independently of GLUT1 transporters-proteins responsible for facilitating glucose entry into cells. This suggests that GPc may serve as a highly effective imaging agent, enhancing the capabilities of PA Tomography in tumor detection.
The implications of this research could be transformative, making tumor detection safer and more affordable for patients. As healthcare costs continue to rise, innovations like GPc not only promise better access to critical diagnostic services but also reduce the risks associated with traditional imaging methods.
This advancement may well pave the way for a new era in cancer detection, characterized by improved accuracy, accessibility, and safety. As the discourse around cancer diagnostics evolves, IISc’s work stands as a promising beacon of hope for patients worldwide.
The research team’s findings contribute significantly to the fields of bioengineering and oncology, potentially changing the landscape of cancer diagnostics in the near future. As more research emerges, the prospect of reliable, cost-effective tumor detection becomes an increasingly attainable reality.
Original Source: https://www.newindianexpress.com/states/karnataka/2025/Aug/11/iisc-researchers-develop-new-imaging-method-to-detect-tumours
Category :
Tags:
Publish Date: 2025-08-11 07:35:00
